Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

7. New RSV prevention options for infants and pregnant mothers A new RSV prevention option for infants was introduced in 2023: the monoclonal antibody treatment Beyfortus (nirsevimab). This shot is ...

covering the critical winter RSV season. Uptake of the nirsevimab program so far in Ireland has been high, with 83 percent of eligible infants receiving the treatment. These results have spurred ...

If you’re feeling under the weather, chances are pretty high that you have one of four popular viruses going around: influenza A (the flu), COVID-19, norovirus (the stomach flu) and respiratory ...

given during pregnancy or an RSV antibody given to infants after birth. Is there a treatment for RSV? What to do if you think you have RSV There is no cure for RSV but symptoms can be treated with ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

SPRINGFIELD/CHICAGO The Illinois Department of Public Health (IDPH) announced that after a one-week dip, the state’s overall ...